President Biden has appointed seven clinicians and researchers to the National Cancer Advisory Board, which advises the Director of the National Cancer Institute on the national cancer research program. The appointments reflect Biden's commitment to ending cancer and investing in research to prevent, detect, and treat the disease. The board will build on the Cancer Moonshot initiative led by Biden in the Obama-Biden Administration. The appointed individuals include Dr. John D. Carpten, Dr. Nilofer S. Azad, Dr. Luis Alberto Diaz Jr., Dr. Christopher R. Friese, Dr. Amy B. Heimberger, Dr. Ashani Weeraratna, and Dr. Karen Winkfield. Each member brings expertise and accomplishments in various areas of cancer research and treatment.